Work

Process evaluation showing the importance of co-located, high-intensity and person-centred smoking cessation support in a lung cancer screening setting

Year: 2026
Type: article
Abstract: Evidence regarding optimal integration of smoking cessation is needed to inform implementation of lung cancer screening (LCS) and reduce smoking-related inequalities. The Yorkshire Enhanced Stop Smoking Randomised Controlled Trial tested opt-out, co-located standard best practice (SBP) smoking cessation support (control) versus SBP enhanced with theory-informed, personalised risk information derived from participants’ lung scan results to boost quit motivation (intervention). The intervention was tailored to degree of lung/heart damage, and designed to optimise self-efficacy and response-efficacy for quitting smoking 1 . Smoking cessation practitioners (SCPs) received bespoke intervention training in delivering theory-informed behaviour change techniques (BCTs). We conducted a nested process evaluation to evaluate the implementation of optimised smoking cessation support compared to SBP. Semi-structured interviews were carried out with 45 trial participants and eight SCPs at 4-, 12- and 52-weeks after screening (participants) or training (SCPs). Interviews were analysed thematically to assess intervention fidelity, exposure, context, contamination and theory. Observations of SCP consultations on the mobile screening unit (n = 84; 4%) and 4-weeks after screening (n = 132; 13%) were analysed to test fidelity, context and contamination. Intervention context was paramount: participants in both trial arms described benefits of co-located and ongoing high-intensity smoking cessation support, with immediate provision of pharmacotherapy. Tailored, non-judgemental care was considered key to initiating and sustaining quitting, particularly for participants at various points along their quit pathway and awaiting a possible lung cancer diagnosis. Fidelity was high (97%) on the screening unit and moderate (75%) 4-weeks after screening, and moderate for the enhanced intervention (77%) 4-weeks after screening. SBP and the intervention was flexibly delivered according to time constraints, participant motivation to quit, anxiety about screening and screening and/or booklet results. There was variation in how participants used and shared their booklets (exposure). Contamination of SCP intervention training was observed, with SCPs delivering theory-informed BCTs across both trial arms e.g. using the LCS context to boost response-efficacy beliefs. Provision of co-located, high intensity and person-centred smoking cessation support was vital, irrespective of trial arm. Investment in specialist LCS smoking cessation practitioners may harness the benefits of LCS as a teachable moment for cessation. Trial registration : www.clinicaltrials.gov/study/NCT03750110 (registered 21/11/2018).
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W4400775229
FWCI: 3.787
Cites: 26
Cited by: 2
Related to: 8